Report Detail

Request for Sample of this report

Service & Software Global Pharmaceutical Asset Performance Management (APM) Market Size, Status and Forecast 2019-2025

  • RnM3466601
    • |
  • 28 May, 2019
    • |
  • Global
    • |
  • 92 Pages
    • |
  • QYResearch
    • |
  • Service & Software

Asset performance management (APM) is a proven approach to reduce unplanned downtime, decrease maintenance costs, and reduce EH&S risks.
Pharmaceutical Asset Performance Management (APM) are mainly classified into the following types: APM Integrity, APM Reliability etc. APM Integrity, is the most widely used type which takes up about 46.1% of the total sales in 2018.
United States is the largest region of Pharmaceutical Asset Performance Management (APM) in the world in the past few years and it will keep increasing in the next few years. United States market took up about 50% the global market in 2018, while Europe and China were about 27%, 7.4%.
APM can extend Enterprise Asset Management (EAM) systems using powerful AI data and analytics. Although sales of Pharmaceutical Asset Performance Management (APM) bring a lot of opportunities, the study group recommends the new entrants who just have money but without technical advantage and downstream support, do not enter the Pharmaceutical Asset Performance Management (APM) field hastily.
In 2018, the global Pharmaceutical Asset Performance Management (APM) market size was 93 million US$ and it is expected to reach 133.1 million US$ by the end of 2025, with a CAGR of 5.3% during 2019-2025.

This report focuses on the global Pharmaceutical Asset Performance Management (APM) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmaceutical Asset Performance Management (APM) development in United States, Europe and China.

The key players covered in this study
GE (US)
Rockwell Software (US)
AVEVA Group plc (UK)
Bentley Systems (US)
AspenTech (US)
Nexus Global (US)
SAP (Germany)
...

Market segment by Type, the product can be split into
Asset Integrity Management
Asset Reliability Management
Other

Market segment by Application, split into
Large Enterprises
SMEs

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Pharmaceutical Asset Performance Management (APM) status, future forecast, growth opportunity, key market and key players.
To present the Pharmaceutical Asset Performance Management (APM) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Pharmaceutical Asset Performance Management (APM) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Pharmaceutical Asset Performance Management (APM) Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Asset Integrity Management
      • 1.4.3 Asset Reliability Management
      • 1.4.4 Other
    • 1.5 Market by Application
      • 1.5.1 Global Pharmaceutical Asset Performance Management (APM) Market Share by Application (2014-2025)
      • 1.5.2 Large Enterprises
      • 1.5.3 SMEs
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Pharmaceutical Asset Performance Management (APM) Market Size
    • 2.2 Pharmaceutical Asset Performance Management (APM) Growth Trends by Regions
      • 2.2.1 Pharmaceutical Asset Performance Management (APM) Market Size by Regions (2014-2025)
      • 2.2.2 Pharmaceutical Asset Performance Management (APM) Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Pharmaceutical Asset Performance Management (APM) Market Size by by Players
      • 3.1.1 Global Pharmaceutical Asset Performance Management (APM) Revenue by by Players (2014-2019)
      • 3.1.2 Global Pharmaceutical Asset Performance Management (APM) Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Pharmaceutical Asset Performance Management (APM) Market Concentration Ratio (CR5 and HHI)
    • 3.2 Pharmaceutical Asset Performance Management (APM) Key Players Head office and Area Served
    • 3.3 Key Players Pharmaceutical Asset Performance Management (APM) Product/Solution/Service
    • 3.4 Date of Enter into Pharmaceutical Asset Performance Management (APM) Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Pharmaceutical Asset Performance Management (APM) Market Size by Type (2014-2019)
    • 4.2 Global Pharmaceutical Asset Performance Management (APM) Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Pharmaceutical Asset Performance Management (APM) Market Size (2014-2019)
    • 5.2 Pharmaceutical Asset Performance Management (APM) Key Players in United States
    • 5.3 United States Pharmaceutical Asset Performance Management (APM) Market Size by Type
    • 5.4 United States Pharmaceutical Asset Performance Management (APM) Market Size by Application

    6 Europe

    • 6.1 Europe Pharmaceutical Asset Performance Management (APM) Market Size (2014-2019)
    • 6.2 Pharmaceutical Asset Performance Management (APM) Key Players in Europe
    • 6.3 Europe Pharmaceutical Asset Performance Management (APM) Market Size by Type
    • 6.4 Europe Pharmaceutical Asset Performance Management (APM) Market Size by Application

    7 China

    • 7.1 China Pharmaceutical Asset Performance Management (APM) Market Size (2014-2019)
    • 7.2 Pharmaceutical Asset Performance Management (APM) Key Players in China
    • 7.3 China Pharmaceutical Asset Performance Management (APM) Market Size by Type
    • 7.4 China Pharmaceutical Asset Performance Management (APM) Market Size by Application

    8 Japan

    • 8.1 Japan Pharmaceutical Asset Performance Management (APM) Market Size (2014-2019)
    • 8.2 Pharmaceutical Asset Performance Management (APM) Key Players in Japan
    • 8.3 Japan Pharmaceutical Asset Performance Management (APM) Market Size by Type
    • 8.4 Japan Pharmaceutical Asset Performance Management (APM) Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Pharmaceutical Asset Performance Management (APM) Market Size (2014-2019)
    • 9.2 Pharmaceutical Asset Performance Management (APM) Key Players in Southeast Asia
    • 9.3 Southeast Asia Pharmaceutical Asset Performance Management (APM) Market Size by Type
    • 9.4 Southeast Asia Pharmaceutical Asset Performance Management (APM) Market Size by Application

    10 India

    • 10.1 India Pharmaceutical Asset Performance Management (APM) Market Size (2014-2019)
    • 10.2 Pharmaceutical Asset Performance Management (APM) Key Players in India
    • 10.3 India Pharmaceutical Asset Performance Management (APM) Market Size by Type
    • 10.4 India Pharmaceutical Asset Performance Management (APM) Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Pharmaceutical Asset Performance Management (APM) Market Size (2014-2019)
    • 11.2 Pharmaceutical Asset Performance Management (APM) Key Players in Central & South America
    • 11.3 Central & South America Pharmaceutical Asset Performance Management (APM) Market Size by Type
    • 11.4 Central & South America Pharmaceutical Asset Performance Management (APM) Market Size by Application

    12 International Players Profiles

    • 12.1 GE (US)
      • 12.1.1 GE (US) Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Pharmaceutical Asset Performance Management (APM) Introduction
      • 12.1.4 GE (US) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2014-2019)
      • 12.1.5 GE (US) Recent Development
    • 12.2 Rockwell Software (US)
      • 12.2.1 Rockwell Software (US) Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Pharmaceutical Asset Performance Management (APM) Introduction
      • 12.2.4 Rockwell Software (US) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2014-2019)
      • 12.2.5 Rockwell Software (US) Recent Development
    • 12.3 AVEVA Group plc (UK)
      • 12.3.1 AVEVA Group plc (UK) Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Pharmaceutical Asset Performance Management (APM) Introduction
      • 12.3.4 AVEVA Group plc (UK) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2014-2019)
      • 12.3.5 AVEVA Group plc (UK) Recent Development
    • 12.4 Bentley Systems (US)
      • 12.4.1 Bentley Systems (US) Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Pharmaceutical Asset Performance Management (APM) Introduction
      • 12.4.4 Bentley Systems (US) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2014-2019)
      • 12.4.5 Bentley Systems (US) Recent Development
    • 12.5 AspenTech (US)
      • 12.5.1 AspenTech (US) Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Pharmaceutical Asset Performance Management (APM) Introduction
      • 12.5.4 AspenTech (US) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2014-2019)
      • 12.5.5 AspenTech (US) Recent Development
    • 12.6 Nexus Global (US)
      • 12.6.1 Nexus Global (US) Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Pharmaceutical Asset Performance Management (APM) Introduction
      • 12.6.4 Nexus Global (US) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2014-2019)
      • 12.6.5 Nexus Global (US) Recent Development
    • 12.7 SAP (Germany)
      • 12.7.1 SAP (Germany) Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Pharmaceutical Asset Performance Management (APM) Introduction
      • 12.7.4 SAP (Germany) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2014-2019)
      • 12.7.5 SAP (Germany) Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Summary:
      Get latest Market Research Reports on Pharmaceutical Asset Performance Management (APM). Industry analysis & Market Report on Pharmaceutical Asset Performance Management (APM) is a syndicated market report, published as Global Pharmaceutical Asset Performance Management (APM) Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Pharmaceutical Asset Performance Management (APM) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,900.00
      		$5,850.00
      		$7,800.00
      		3,014.70
      		4,522.05
      		6,029.40
      		3,630.90
      		5,446.35
      		7,261.80
      		595,491.00
      		893,236.50
      		1,190,982.00
      		329,160.00
      		493,740.00
      		658,320.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo